Type 2 Diabetes (T2D) has emerged as a global health challenge, affecting millions worldwide. It is a chronic condition characterized by insulin resistance and the inability to regulate blood sugar levels effectively. While conventional treatments like medication and lifestyle changes are helpful, they often fall short in addressing the root cause of the disease. This […]
The video below titled “Beta Cells From Stem Cells Nearing a Cure for Type 1 Diabetes” features Dr. Anne L. Peters discussing the results of clinical trials involving beta cells derived from stem cells in patients with type 1 diabetes. The trials were conducted by a company named Vertex, for which Dr. Peters serves on […]
If you’re reading this, chances are you or someone you love is grappling with diabetes. It’s a tough journey, isn’t it? The constant monitoring of blood sugar levels, the dietary restrictions, the insulin injections – it can all feel overwhelming. But what if I told you there’s a glimmer of hope on the horizon? What […]
In this round table video clip, Dr. Camillo Ricordi and Dr. Melena Bellin discuss the current strategies being studied for restoring glycemic control in Type 1 Diabetes with stem cells.
Kadimastem Receives Approval of Patent Registration for Its Cell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes in a Third Territory
NESS ZIONA, Israel, Sept. 28, 2022 /PRNewswire/ — Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing treatments for ALS and diabetes, has been granted its third patent approval for the company’s innovative cell selection and enrichment technology and its use in the production of IsletRx, the company’s treatment and potential cure for diabetes. […]
CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world’s premier diabetic foot conference (DFCon) in Los Angeles
LOS ANGELES, Sept. 26, 2022 /PRNewswire/ — CRC is delighted to announce attendance at DFCon, the global specialist multidisciplinary congress focused on the diabetic foot held in late September 2022 in Los Angeles, USA. The meeting is a gathering of a wide range of both generalists and specialists who diagnose and manage diabetic feet, to […]
GERMANTOWN, Md., Aug. 30, 2022 (GLOBE NEWSWIRE) — The regenerative medicine company Seraxis Inc. today announced the appointment of Paul Strumph, M.D. as Chief Medical Officer. Dr. Strumph is an endocrinology and diabetes care and research specialist with a successful career of bringing anti-diabetes treatments to market. He will drive the company’s clinical and medical […]
UCI Sue and Bill Gross Stem Cell Research Center Virtual Community Lecture featuring Ronke Olabisi, PhD discussing mesenchymal stem cells in wound healing.
Biorep Technologies, Inc. Joins the Tetra Partner Network to Accelerate Research into Stem-Cell Derived Insulin to Cure Diabetes
BOSTON, May 31, 2022 /PRNewswire/ — TetraScience, the R&D Data Cloud company, announced today that Biorep Technologies, Inc., the leading provider of scientific instruments that help pharmaceutical companies and leading universities research cures for Type 1 and Type 2 diabetes, has joined the Tetra Partner Network. The partnership builds on a joint deployment of Biorep’s […]
Did you know that Type-1 diabetes is a life-threatening autoimmune disease? If not, you’re not alone. Many people are unaware of the seriousness of this disease. Cause of Type-1 Diabetes Type-1 diabetes is caused by the body’s immune system attacking and destroying the insulin-producing cells in the pancreas. This means that the body can no […]